Cargando…

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits

Polycystic ovary syndrome (PCOS) is an endocrine disorder among women of reproductive age characterized by chronic anovulation and polycystic ovary morphology and/or hyperandrogenism. Management of clinical manifestations of PCOS, such as menstrual irregularities and hyperandrogenism symptoms, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Melo, Anderson Sanches, dos Reis, Rosana Maria, Ferriani, Rui Alberto, Vieira, Carolina Sales
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774551/ https://www.ncbi.nlm.nih.gov/pubmed/29386951 http://dx.doi.org/10.2147/OAJC.S85543

Ejemplares similares

Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
por: Nappi, Rossella E, et al.
Publicado: (2014)

Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice
por: Melo, Anderson Sanches, et al.
Publicado: (2015)

Nutritional Counseling Promotes Changes in the Dietary Habits of Overweight and Obese Adolescents with Polycystic Ovary Syndrome
por: Carolo, Adriana Lúcia, et al.
Publicado: (2017)

Physical Performance Regarding Handgrip Strength in Women with Polycystic Ovary Syndrome
por: Kogure, Gislaine Satyko, et al.
Publicado: (2020)

Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome
por: Ribeiro, Victor Barbosa, et al.
Publicado: (2019)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Increased Sympathetic Cardiac Autonomic Modulation after Two Consecutive Tilt Tests in Women with Polycystic Ovary Syndrome
por: Ribeiro, Victor Barbosa, et al.
Publicado: (2020)

Lifestyle, Anxiety,Depression, and Clinical Profile in Women With Polycystic Ovary Syndrome: Initial Results From the Brazilian PCOS Study
por: Spritzer, Poli Mara, et al.
Publicado: (2021)

Prevalence and characteristics of polycystic ovary syndrome in Brazilian women: protocol for a nation-wide case–control study
por: Spritzer, Poli Mara, et al.
Publicado: (2019)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
por: de Medeiros, Sebastião Freitas
Publicado: (2017)

Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index
por: Kogure, Gislaine Satyko, et al.
Publicado: (2023)

Non-Contraceptive Benefits of Oral Hormonal Contraceptives
por: Schindler, Adolf E
Publicado: (2012)

Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome
por: Montezuma, Thais, et al.
Publicado: (2011)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
por: Spritzer, Poli Mara
Publicado: (2022)

Benefits and risks of hormonal contraception for women
por: Gorenoi, Vitali, et al.
Publicado: (2007)

Aerobic physical training impact on adipokines in women with polycystic ovary syndrome – Effects of body fat percentage
por: de Souza, Hugo Celso Dutra, et al.
Publicado: (2022)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
por: Park, Chan-Hong, et al.
Publicado: (2020)

Recent advances in the understanding and management of polycystic ovary syndrome
por: Rocha, Ana L., et al.
Publicado: (2019)

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

Presentation and treatment of uterine leiomyoma in adolescence: a systematic review
por: Moroni, Rafael Mendes, et al.
Publicado: (2015)

Fertility optimization in women with cancer: from preservation to contraception
por: de Melo, Anderson Sanches, et al.
Publicado: (2019)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
por: McCartney, Christopher R., et al.
Publicado: (2022)

Women with Polycystic Ovarian Syndrome Exhibit Reduced Baroreflex Sensitivity That May Be Associated with Increased Body Fat
por: Philbois, Stella Vieira, et al.
Publicado: (2019)

Hormonal Contraception and HIV/AIDS Transmission: Challenges for Zimbabwe’s Reproductive Health Service Providers in Promoting Informed Contraception Choices
por: Mafuva, Christopher, et al.
Publicado: (2013)

Does structured counselling influence combined hormonal contraceptive choice?
por: Merckx, Mireille, et al.
Publicado: (2011)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice
por: Zhang, Hong, et al.
Publicado: (2023)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome
por: Mu, Liangshan, et al.
Publicado: (2018)

The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents
por: Khashchenko, Elena, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Reproductive Hormones in Women With Polycystic Ovary Syndrome
por: Khalid, Karniza, et al.
Publicado: (2023)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2016)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_52a55m4388m5fjqfb47b0auns6